Due Diligence in Healthcare Private Equity Transactions

This CLE course will guide counsel in healthcare private equity transactions on due diligence measures that effectively identify and mitigate risks and liabilities. The panel will address the regulatory and corporate practice of medicine issues that should be considered during the due diligence process.

Private equity firms play an active role in healthcare deals. As with any healthcare deal, the parties involved in healthcare private equity transactions should conduct thorough due diligence before closing the deal. The parties should consider potential successor liability, pending or threatened litigation, current contracts that could trigger penalties, and more. Because healthcare entities are highly regulated, parties to these transactions should conduct significant healthcare regulatory due diligence.

Counsel should also review current ownership structures to minimize the risk of corporate practice of medicine issues. Other regulatory considerations during the due diligence process include compliance with Stark Law, Anti-Kickback Statute, False Claims Act, and HIPAA, as well as the state law equivalents.

Listen as our authoritative panel examines due diligence in healthcare private equity transactions and why the due diligence process should be carefully structured and implemented. The panel will discuss the legal issues to address in healthcare due diligence, including key healthcare risk areas and requirements, compliance programs, Medicare/Medicaid changes of ownership, licenses, and permits. The panel will offer best practices for conducting due diligence in healthcare transactions.